Oxford Instruments Nanoscience partners with Oxford Quantum Circuits

Oxford Instruments Nanoscience

Oxford Instruments NanoScience, the Abingdon-based pioneer in dilution refrigerator technology, has announced a partnership with Reading-based Oxford Quantum Circuits (OQC), to accelerate quantum computing commercialisation in the UK. As part of the collaboration, OQC is taking delivery of Oxford Instruments’ next generation Cryofree® refrigerator, Proteox.

Dilution refrigerator technology provides continuous cooling in very, very low temperatures.

Proteox was specifically designed to facilitate high-density wiring with insert-modulatory. OQC will leverage these features to enhance the scaling of its unique 3D architecture, also paving the way towards quantum-focused Measurements as a Service capability.

OQC, which has built the UK’s most advanced superconducting quantum computer and the only one commercially available in the country,  is the first company worldwide to take delivery of the Proteox.

OQC CEO Ilana Wisby said: “Our collaboration with Oxford Instruments NanoScience and our work with Proteox is a significant milestone in our plans to build a quantum-powered future. Proteox will complement our equipment capability in our new state-of-the-art laboratory, further enabling our customers to access our technology online and on site.”

The technology OQC is developing is at the leading edge of quantum computing, which will help in the discovery of new medical treatments, and solving some of humanity’s greatest problems such as combating climate change.

Stuart Woods, Managing Director of Oxford Instruments NanoScience, which is part of the Oxford Instruments plc group, said: “This announcement demonstrates how Oxford Instruments is ensuring that the innovators in quantum computing like OQC have access to the best platform for the development of next generation quantum technologies, from early stage single qubit research, right through to commercial quantum computer scale-up, opening up new territories for quantum commercialisation today – not tomorrow. This is great news for the UK’s quantum push.”

Proteox is a next-generation Cryofree system that provides a step change in modularity and adaptability for ultra-low temperature experiments in condensed-matter physics and quantum computing industrialisation. The Proteox platform has been developed to provide a single, interchangeable modular solution that can support multiple users and a variety of set-ups or experiments while also enabling remote management.

Quantum computing offers the chance for businesses to find better or quicker ways to solve problems, many of which are not possible using standard computers. Industries including pharmaceuticals, aerospace and transport that substantially contribute to the UK economy are set to benefit most. This is because this technology could help them to accelerate the discovery of new drug treatments, improve the efficiency of global supply chains including across food, automotive and aerospace sectors, and cut road traffic in towns and cities, shortening people’s commuting times while reducing pollution levels – and benefiting people’s lives and businesses.

By 2024, quantum computing is expected to provide £4 billion of economic opportunities globally, while in the coming decades productivity gains resulting from quantum computing are expected to surpass over £341 billion globally.